Free Trial
NASDAQ:GCTK

GlucoTrack (GCTK) Stock Price, News & Analysis

$2.32
-0.10 (-4.13%)
(As of 06/18/2024 ET)
Today's Range
$2.32
$2.42
50-Day Range
$1.87
$4.51
52-Week Range
$0.66
$4.95
Volume
3,419 shs
Average Volume
34,100 shs
Market Capitalization
$12.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GlucoTrack MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.44% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.30mentions of GlucoTrack in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$230,000 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.32 out of 5 stars

Medical Sector

883rd out of 913 stocks

Surgical & Medical Instruments Industry

96th out of 98 stocks

GCTK stock logo

About GlucoTrack Stock (NASDAQ:GCTK)

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

GCTK Stock Price History

GCTK Stock News Headlines

Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.
GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT
GlucoTrack, Inc. (GCTK)
UK mortgage arrears rise 50% amid high interest rates
Glucotrack names Luis Malavé board chair
See More Headlines
Receive GCTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
6/18/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:GCTK
Employees
6
Year Founded
N/A

Profitability

Net Income
$-7,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.77 per share

Miscellaneous

Free Float
4,509,000
Market Cap
$13.15 million
Optionable
Not Optionable
Beta
0.13
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Paul V. Goode Ph.D. (Age 55)
    Chief Executive Officer
    Comp: $225k
  • Mr. Mark Tapsak Ph.D. (Age 55)
    Vice President of Technology
    Comp: $165k
  • Ms. Drinda Benjamin (Age 48)
    Vice President of Marketing
  • Mr. James P. Thrower Ph.D. (Age 54)
    Vice President of Engineering
    Comp: $230k
  • Mr. Avner Gal MBA (Age 70)
    MSc.EE, Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board
    Comp: $187.39k
  • Mr. David Malka BA (Age 59)
    Co-Founder
    Comp: $191.86k
  • Mr. James S. Cardwell (Age 63)
    Chief Financial Officer

GCTK Stock Analysis - Frequently Asked Questions

How have GCTK shares performed in 2024?

GlucoTrack's stock was trading at $1.3075 on January 1st, 2024. Since then, GCTK shares have increased by 77.4% and is now trading at $2.32.
View the best growth stocks for 2024 here
.

Are investors shorting GlucoTrack?

GlucoTrack saw a increase in short interest in May. As of May 31st, there was short interest totaling 16,500 shares, an increase of 931.3% from the May 15th total of 1,600 shares. Based on an average daily trading volume, of 40,900 shares, the short-interest ratio is presently 0.4 days. Currently, 0.4% of the shares of the company are short sold.
View GlucoTrack's Short Interest
.

When is GlucoTrack's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our GCTK earnings forecast
.

How were GlucoTrack's earnings last quarter?

GlucoTrack, Inc. (NASDAQ:GCTK) released its earnings results on Wednesday, May, 15th. The company reported ($0.60) earnings per share for the quarter.

When did GlucoTrack's stock split?

Shares of GlucoTrack reverse split on Monday, May 20th 2024. The 1-5 reverse split was announced on Monday, May 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

How do I buy shares of GlucoTrack?

Shares of GCTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GCTK) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners